Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101108162 | 10110816 | 2 | F | 20071023 | 20140305 | 20140425 | 20141231 | EXP | US-GSKPPD-2014GSK009889 | GLAXOSMITHKLINE | 66.87 | YR | F | Y | 0.00000 | 20141231 | N | MD | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101108162 | 10110816 | 1 | PS | AVANDIA | ROSIGLITAZONE MALEATE | 1 | ORAL | AVANDIA WAS NOT LISTED AMONG THE PATIENTS RECORDS REVIEWED. | D | 21071 | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101108162 | 10110816 | 1 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101108162 | 10110816 | HO |
| 101108162 | 10110816 | OT |
| 101108162 | 10110816 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101108162 | 10110816 | Cerebral haemorrhage | |
| 101108162 | 10110816 | Vascular graft |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |